Release
📈 Stocks
Relmada Therapeutics Appoints Jørn Skibsted Jakobsen as Chief Development Officer
(just now)
Relmada Therapeutics adds former Ferring Pharmaceuticals executive Jørn Skibsted Jakobsen to its leadership team to spearhead the Phase 3 SPECTRUM registrational program…